Summary
In Malaysia, Tinospora crispa extract is taken orally by Type 2 (non-insulin-dependent) diabetic patients to treat hyperglycaemia. We have evaluated the claimed hypoglycaemic property by adding aqueous extract to the drinking water of normal and alloxan-diabetic rats. After one week, fasting blood glucose levels were significantly (p<0.01) lower and serum insulin levels were significantly (p<0.01) higher in treated diabetic animals (10.4±1.0 mmol/l and 12.8±1.1 μU/ml respectively) compared to untreated diabetic controls (17.4±1.7 mmol/l and 8.0±0.7 μU/ml respectively). The insulinotropic action of T. crispa was further investigated in vitro using isolated human or rat islets of Langerhans and HIT-T15 cells. In static incubations with rat islets and HIT-T15 B cells, the extract induced a dosage dependent stimulation and potentiation of basal and glucose-stimulated insulin secretion respectively. This insulinotropic effect was also evident in perifused human and rat islets and HIT-T5 B-cells. The observations that (i) in all three models insulin secretory rates rapidly returned to basal levels on removal of the extract and (ii) in rat islets, a second challenge with T. crispa induced an additional, stimulated response, are all consistent with physiological release of insulin by B cells. Moreover, the rate of HIT-T15 glucose utilisation was not affected by incubation with T. crispa, suggesting that the cells were viable throughout. These are the first studies to provide biochemical evidence which substantiates the traditional claims for an oral hypoglycaemic effect of Tinospora crispa, and which also show that the hypoglycaemic effect is associated with increased insulin secretion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Asmal AC, Marble A (1984) The oral hypoglycaemic agents. An update. Drugs 28: 62–78
University Group Diabetes Program (1974) A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes: section V. Evaluation of phenformin therapy. Diabetes 24 (Suppl.1): 65–184
Knatterud G, Klimt CR, Levin ME, Jacobsen ME, Goldner MG (1978) Effect of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes: section VIII. Mortality and selected nonfatal events with insulin treatment. JAMA 240: 37–42
Reaven GM (1983) Therapeutic approaches to reducing insulin resistance in patients with noninsulin-dependent diabetes mellitus. Am J Med 74: 109–112
Jenkins DJA, Wolever TMS, Leeds AR, Gassull MA, Haisman P, Dilawari JB, Goff DV, Metz GL, Alberti KGMM (1978) Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1: 1992–1994
Ajgaonkar SS (1979) Herbal drugs in the treatment of diabetes. A review. International Diabetes Federation Bulletin 24: 10–19
Weragoda B (1970) Some questions about the future of traditional medicine in developing countries. J Ethnopharmacol 2: 193–194
Burkill LH (1966) A dictionary of the economic products of the Malay Peninsula: vol II. Ministry of Agriculture and Cooperations, Kuala Lumpur, pp 2202–2205
Hirschhorn HH (1983) Botanical remedies of the former Dutch East Indies (Indonesia). Part II: Dicotyledons up to and including Leguminosae. J Ethnopharmacol 8: 65–96
Gimlette JD, Burkill LH, Ismail Munshi (1930) The medicinal book of Malayan Medicine. Gard Bull Str Settle 6: 323–474
Lazarow A, Palay SL (1946) The production and course of alloxan diabetes in the rats. J Lab Clin Med 31: 1004
Sutton R, Peters M, McShane P, Gray DWR, Morris PJ (1986) An improved method for the isolation of islets of Langerhans from the adult rat pancreas. Transplant Proc 18: 1819–1820
Gray DWR, McShane P, Grant AM, Morris PJ (1984) A method for isolation of islets of Langerhans from the human pancreas. Diabetes 33: 1055–1061
Ashcroft SJH, Hammonds P, Harrison DE (1986) Insulin secretory responses of a clonal cell line of simian virus 40-transformed B-cells. Diabetologia 29: 727–733
Ashcroft SJH, Crossley JR (1975) Effects of glucose, N-acetylglucosamine, glyceraldehyde and other sugars on insulin release in vivo. Diabetologia 11: 279–284
Ashcroft SJH, Weerasinghe LCC, Bassett JM, Randle PJ (1972) The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 126: 525–532
Farnsworth NR, Bingel AS (1977) Problems and prospects of discovering new drugs from higher plants by pharmacological screening. In: Wagner H, Wolff P (eds) New natural products and plant drugs with pharmacological, biological or therapeutic activity. Springer, Berlin Heidelberg New York, pp 1–22
Bever BO, Zahnd GR (1979) Plants with oral hypoglycaemic action. Quart J Crude Drug Res 17: 139–196
Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22: 485–517
Albano JDM, Ekins RP, Maritz G, Turner RC (1972) A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70: 487–509
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noor, H., Hammonds, P., Sutton, R. et al. The hypoglycaemic and insulinotropic activity of Tinospora crispa: studies with human and rat islets and HIT-T15 B cells. Diabetologia 32, 354–359 (1989). https://doi.org/10.1007/BF00277258
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00277258